| Filed On | Filing |
|---|---|
| 01 Oct 2025 |
Form 3: Jia Dengyao, Director
No securities owned |
| 23 Aug 2024 |
Form 3: Zhang Hong, Director
Holds 240,481 shares of Common Stock |
| 10 Oct 2023 |
Form 3: Xu Jiandong, Chief Financial Officer
Holds 264,388 shares of Common Stock |
| 10 Oct 2023 |
Form 3: Roberts Marsha, Director
No securities owned |
| 10 Oct 2023 |
Form 3: Xu Pei, Director
No securities owned |
| 10 Oct 2023 |
Form 3: Liu Cheng, Director
Holds 297,437 shares of Common Stock |
| 10 Oct 2023 |
Form 3: Wu Xuejun Janelle, Director
No securities owned |
| 10 Oct 2023 |
Form 3: Wu Fan, Director
No securities owned |
| 10 Oct 2023 |
Form 3: Eureka Therapeutics, Inc., 10% owner
Holds 25,277,831 shares of Common Stock |
| 09 Jan 2023 |
Form 3: Owl Creek Asset Management, L.p., 10% owner
Holds 255,000 shares of Common Stock, par value $0.0001 per share |
| 26 Jul 2021 |
Form 3: Jiang Tao, Director
Holds 10,000 shares of Common Stock |
| 22 Jul 2021 |
Form 3: Twigg Weston, Director
Holds 10,000 shares of Common Stock |
| 22 Jul 2021 |
Form 3: Long James, Director
Holds 10,000 shares of Common Stock |
| 22 Jul 2021 |
Form 3: Yang Weiguang, Director
No securities owned |
| 22 Jul 2021 |
Form 3: TradeUP Acquisition Sponsor Llc, 10% owner
Holds 1,145,760 shares of Common Stock |
| 22 Jul 2021 |
Form 3: Wen Luqi, Chief Financial Officer
No securities owned |
| 22 Jul 2021 |
Form 3: Li Jianwei, Director
Holds 1,145,760 shares of Common Stock |
Loading...